Tanning peptides and influencer culture: what the science says

What's this video probably claiming?

Given the hashtags referencing David Laid, a well-known fitness influencer, and the explicit "tan" tag alongside a peptide category classification, this video is almost certainly discussing melanotan II (MT-II) or afamelanotide, the synthetic melanocortin peptides that bodybuilding and fitness communities have adopted as a shortcut to darker skin without sun exposure. David Laid has been discussed in online forums in connection with aesthetic peptides, making this context fairly predictable. The creator is likely describing how the peptide works, referencing personal results, or walking through a protocol they or someone else followed. These videos typically frame tanning peptides as a simple, low-risk way to achieve a competition-ready or camera-ready tan, often without serious discussion of the regulatory status or the actual clinical data behind what these compounds do in a human body at the doses being circulated on social media.

What does the science actually show?

Afamelanotide (the stabilized alpha-MSH analog, brand name Scenesse) is the only melanocortin peptide with genuine regulatory approval, and it is specifically approved by the FDA and EMA for erythropoietic protoporphyria, a rare photosensitivity disorder. That's a narrow indication. Melanotan II, the compound most commonly discussed in bodybuilding communities, has no approved clinical use anywhere. Research on MT-II has been conducted, including early-phase work by Hadley et al. (2000, Peptides) showing dose-dependent tanning responses and nausea at doses as low as 0.025 mg/kg, but the compound was never advanced through full clinical trials because of a problematic side effect profile including spontaneous erections, nausea, flushing, and, more concerning, reports of melanocytic nevus changes. A 2011 paper by Langan et al. in the Journal of Clinical and Aesthetic Dermatology documented multiple case reports of existing moles changing characteristics following MT-II use, which is not a trivial concern given that atypical nevus changes are a dermatology red flag.

Where does the social media noise diverge from clinical reality?

The gap here is substantial. Social media framing almost always presents tanning peptides as a cosmetic convenience, a way to look better in photos or on stage. What gets omitted is the uncontrolled dosing, the unsterile compounding sources, and the complete absence of long-term safety data for MT-II in healthy people. Fitness influencer culture treats anecdotal results as evidence, but a TikTok tan is not a clinical endpoint. The nevus change data is particularly relevant and almost never mentioned in creator content. Beyond that, MT-II's stimulation of MC1R and MC3R receptors does more than trigger melanogenesis. MC3R and MC4R activation affects appetite suppression and sexual function, which is why spontaneous erections and appetite changes are documented adverse effects, not rare outliers. Validated case series from dermatology literature, including work cited in the British Journal of Dermatology, document MT-II-associated pigmented lesion changes that required dermatological evaluation. None of this makes it into a 60-second TikTok.

What should you actually know?

Melanotan II is not FDA-approved for any indication. It is not legally sold as a drug in the United States, the UK, or the EU for human use. Purchasing it from research chemical suppliers or gray-market peptide vendors means you have no guarantee of purity, sterility, or actual peptide concentration. A 2019 analysis by the UK's Medicines and Healthcare products Regulatory Agency found significant variability in MT-II products seized from online vendors, including incorrect dosing and contamination. If you are considering any melanocortin peptide for a legitimate medical reason, such as erythropoietic protoporphyria or another photosensitivity condition, afamelanotide through a licensed prescriber is the only evidence-backed path. Chasing a tan through an unapproved injectable peptide sourced online, because an influencer posted results, is a risk-to-benefit calculation that does not hold up when you look at the actual literature rather than the comment section.